Mounjaro 5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F8N8M
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,759
Award facts
- Contract value 100% obligated
- $21,759.49 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $21,759.49 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro (tirzepatide) 5 mg/0.5 mL pens on January 30, 2026, with completion expected by February 2, 2026. This is a non-set-aside competitive award issued under a larger vehicle—specifically the Defense Logistics Agency Troop Support Medical Indefinite Delivery Contract valued at up to $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor, with its parent company Cencora, Inc. holding the master IDC. The product will be performed and delivered from AmerisourceBergen's Conshohocken facility.
Mounjaro is a GLP-1 receptor agonist used for diabetes management and has become an increasingly common pharmaceutical item in federal medical procurement. This delivery order represents one of numerous pharmaceutical supply orders placed by the Defense Logistics Agency to support military healthcare systems, the Defense Health Agency, and other federal medical institutions. The firm fixed-price structure and competitive award process reflect AmerisourceBergen's established capability to meet federal pharmaceutical procurement requirements across a diverse portfolio of medications spanning multiple therapeutic domains, from specialty treatments to routine pharmaceuticals.
Quick answers
Who was awarded contract SPE2DR26F8N8M?
SPE2DR26F8N8M was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 30, 2026.
How much is contract SPE2DR26F8N8M worth?
The government has obligated $21,759 on SPE2DR26F8N8M.
Is contract SPE2DR26F8N8M an order under another contract?
Yes. SPE2DR26F8N8M is a delivery order under SPE2DR25D3022, an indefinite delivery contract.
Was contract SPE2DR26F8N8M competed?
The extent of competition for SPE2DR26F8N8M was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award